Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease

Abstract
No abstract available
Funding Information
  • National Institute of Allergy and Infectious Disease of the US (HHSN272201000019I-HHSN27200003, AI110700, AI089728)